Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab-Reference-Cited by-同舟云学术

Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab

Published:2019-03-06 Issue:5 Volume:8 Page:e1580128
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Popinat Geoffrey¹,Cousse Stéphanie²,Goldfarb Lucas³,Becker Stéphanie¹⁴,Gardin Isabelle¹⁴,Salaün Mathieu²⁴,Thureau Sébastien¹⁴⁵,Vera Pierre¹⁴,Guisier Florian²^ORCID,Decazes Pierre¹⁴^ORCID

Affiliation:

1. Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France

2. Department of Pulmonology, Thoracic Oncology, and Respiratory Intensive Care, Rouen University Hospital, Rouen, France

3. Department of Nuclear Medicine, Hôpital Avicenne, Bobigny, France

4. Faculty of Medicine, University of Rouen, Rouen, France

5. Department of Radiotherapy and Oncology, Henri Becquerel Cancer Center, Rouen, France

Funder

No funding

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy